2
738 Speeialia EXPERIENTIA33/6 creasing amplitude of the b-wave (strong veratrinization) isolating the slow-decaying negative potential which might be referred to as the PIII component. Difference between effective doses of weak and strong veratriniza- tion in the retina is smalId,% as in other tissue< In fig- ure 1, almost no effect was observed in appearance by veratridine administration (weak veratrinization). How- ever, by administration of 2 • 10 .3 M sodium aspartate (which is usually enough to abolish the PII component and to isolate the PIII componentS), PIII as well as PII disappeared. In figure 2, the PIII component was iso- lated at first by administration of 2 • .3 M sodium aspartate. Sodium aspartate by itself is a Very safe chemi- cal as sodium salt, and PIII, isolated by sodium aspartate of this level of concentration, is always very stable s To this retina, veratridine of 6 • 10 -6 M was administrated. Then, PIII was markedly reduced in amplitude and dis- appeared in 10-15 min. On the recording of 18 min, a moderate positive wave of 600-700 msec peak latency was observed. An important finding in these experiments was that generation of PIII component as well as the PlI component of ERGs was severely damaged by simulta- neous presence of veratridine and sodium aspartate in perfusate. Hanitzsch s studied effects of sodium aspartate upon the rabbit retina and analyzed PlII into 3 subcom- ponents, a) an aspartate-insensitive distal PIII, b) an aspartate-sensitive PlII, and c) an aspartate-insensitive slow PlII. Pill isolated in this study might be referred to a) or c), or a mixture of both subcomponents of Hanitzsch 8. Further analysis is impossible in this study employing superficial electrodes, but it might be said that veratridine effects (weak and strong veratrinization) on the PlI and aspartate-insensitive PIII components of perfused rabbit retinas were modified by presence of sodium aspartate, or in other words, that effects of sodium aspartate were modified by the presence of veratridine. 6 Y. Honda, Acta Soc. ophthal, jap. 81, 135 (1977). 7 Y. Honda, Acta Soc. ophthal, jap. 8?, 139 (1977). 8 T. Furukawa and I. Hanawa, Jap. J. Physiol. 5, 289 (1955). 9 R. Hanitzseb, Vision Res. ?3, 2093 (1973). Sex factors and plasma levels of oxytetracycline (OTC) in rats 1 Darinka Dekanid, Mirjana Kupinid% Tea Maljkovi6 and D. Kello 3 Institute [or Medical Research and Occupational Health, Mote Pijade 158, Y-41000 Zagreb (Yugoslavia), 20 October 7976 Summary. Sex related differences in plasma OTC concentrations were found in rats 4-24 h after a single i.p. application of 100 and 50 mg/kg OTC. Reports on bone retention of tetracyclines in rats indicate that age and sex significantly influence the deposition of these antibiotics in the skeleton a-6. The differences were either not specially commented upon 5 or the authors tried to interpret them as an indicator of different bone growth< It was also assumed that they could be due to other changes in the metabolism of antibiotics in the body caused by age or sex 6. In the present paper the in- fluence of sex factors on plasma levels of OTC was in- vestigated as a possible explanation of different OTC re- tention in the bone, and as a factor which might be re- levant for assessing the general efficiency of the OTC treatment. Methods and results. The experimental animals, 12-month- old male and female albino rats (body weights 425 t 18 g and 254 _k 13 g, respectively) and 12-month-old ovariecto- mized animals (body weight 280 I 8 g; ovaries removed at the age of 4 months) were injected i.p. with 100 mg/kg OTC (Geomycin, Pliva, Zagreb). 2 lower doses of OTC, 10 and 50 mg/kg were injected in the same way to male and female rats of similar age (12-13 months old) and body weights (434 t 7, 256 ! 5 g). Blood samples were taken 1, 4, 8, 24 and 48 h after OTC application from the orbital venous plexus and plasma was separated by een- trifugation at 5000 rev/min (3000 • for 10 min. The concentration of the antibiotic was assayed on agar plates against Sarcina Lutes. It can be seen on table 1 that 1 h Mter administration of 100 mg/kg OTC plasma levels of OTC were practically the same in all groups of animals. After 4 h, the values for males and ovariectomized females Table 1. OTC concentrations in plasma ([zg/ml) after a single i.p. injection of 100 mg/kg* Time after dose (h) 1 4 8 24 Female rats A) controls 48.911.0 46.0tl.4 20.0!2.0 2.7t0.1 B) ovariectomized 49.210.6 81.1t4.7 33.5t5.0 3.7t0.3 Male rats C) controls 47.1t3.3 76.0~ 5.4 48.5t3.9 4.0t0.6 A:C p>0.1 p<0.001 p<0.001 p<0.05 A:B p>0.] p<0.001 p<0.02 p<0.001 B:C p>0.1 p>0.1 p<0.02 p>0.1 Table 2. OTC concentrations in plasma (Exg/ml) after a single i.p. injection* Dose Sex Time after dose (h) mglkg 1 4 8 A) female 22.011.8 10.5• 0.5!0.01 50 B) male 19.0• 8.9• 3.5t0.3 C) female 4.1+0.2 1.310.1 10 D) male 3.81t-0.4 1.410.2 A:B p>O.l p>O.l C :D p>O.l p>O.l p <0.001 * Each figure represents the mean of 8 animals ! SE. * Each figure represents the mean of 8-12 animals 1 SE.

Sex factors and plasma levels of oxytetracycline (OTC) in rats

Embed Size (px)

Citation preview

Page 1: Sex factors and plasma levels of oxytetracycline (OTC) in rats

738 Speeialia EXPERIENTIA 33/6

creasing ampl i tude of the b -wave (strong verat r in izat ion) isolat ing the s low-decaying nega t ive po ten t ia l which migh t be referred to as the P I I I component . Difference be tween effect ive doses of weak and s t rong vera t r in iza- t ion in the re t ina is smalId,% as in o ther t i ssue< In fig- ure 1, a lmost no effect was observed in appearance by vera t r id ine admin i s t r a t ion (weak vera t r in iza t ion) . How- ever, by admin i s t r a t ion of 2 • 10 .3 M sodium aspar ta te (which is usual ly enough to abolish the P I I componen t and to isolate the P I I I componentS), P I I I as well as P I I disappeared. In figure 2, the P I I I componen t was iso- la ted a t f irst b y admin is t ra t ion of 2 • .3 M sodium aspar ta te . Sodium aspar ta te by itself is a Very safe chemi- cal as sodium salt , and P I I I , isolated by sodium aspar ta te of this level of concentra t ion, is a lways v e r y stable s To this ret ina, vera t r id ine of 6 • 10 -6 M was adminis t ra ted . Then, P I I I was marked ly reduced in ampl i tude and dis- appeared in 10-15 min. On the recording of 18 min, a modera te posi t ive wave of 600-700 msec peak la tency was observed. An i m p o r t a n t f inding in these exper iments was t h a t generat ion of P I I I componen t as well as the P l I

componen t of E R G s was severely damaged by s imulta- neous presence of vera t r id ine and sod ium aspar ta te in perfusate. Han i t z sch s s tudied effects of sodium aspar ta te upon the rabb i t re t ina and analyzed P l I I into 3 subcom- ponents , a) an aspar ta te- insensi t ive dis tal PIII, b) an aspartate-sensitive PlII, and c) an aspar ta te- insens i t ive slow P l I I . P i l l isolated in th is s t udy migh t be referred to a) or c), or a mix tu re of bo th subcomponents of Han i t z sch 8. Fu r the r analysis is impossible in th is s tudy employing superficial electrodes, bu t i t migh t be said t h a t vera t r id ine effects (weak and s t rong veratr inizat ion) on the P l I and aspar ta te - insens i t ive P I I I components of perfused rabb i t re t inas were modif ied by presence of sodium aspar ta te , or in o ther words, t h a t effects of sodium aspar ta te were modif ied by the presence of veratr idine.

6 Y. Honda, Acta Soc. ophthal, jap. 81, 135 (1977). 7 Y. Honda, Acta Soc. ophthal, jap. 8?, 139 (1977). 8 T. Furukawa and I. Hanawa, Jap. J. Physiol. 5, 289 (1955). 9 R. Hanitzseb, Vision Res. ?3, 2093 (1973).

Sex factors and plasma levels of oxytetracycline (OTC) in rats 1

Dar inka Dekanid, Mir jana Kupinid% Tea Maljkovi6 and D. Kello 3

Institute [or Medical Research and Occupational Health, Mote Pijade 158, Y-41000 Zagreb (Yugoslavia), 20 October 7976

Summary. Sex re la ted differences in p lasma OTC concent ra t ions were found in rats 4-24 h af ter a single i.p. appl ica t ion of 100 and 50 mg/kg OTC.

Repor t s on bone re ten t ion of te t racycl ines in ra ts indicate t h a t age and sex s ignif icant ly influence the deposi t ion of these ant ib io t ics in t he skeleton a-6. The differences were e i ther n o t special ly c o m m e n t e d upon 5 or t he authors t r ied to in te rpre t t h e m as an indica tor of different bone g rowth< I t was also assumed t h a t t h e y could be due to o ther changes in t he metabo l i sm of ant ib iot ics in the body caused by age or sex 6. I n the present paper the in- f luence of sex factors on p lasma levels of OTC was in- ves t iga ted as a possible exp lana t ion of di f ferent OTC re- t en t ion in the bone, and as a fac tor which migh t be re- l evan t for assessing the general eff iciency of t he OTC t r e a t m e n t . Methods and results. The exper imenta l animals, 12-month- old male and female albino ra ts (body weights 425 t 18 g

and 254 _k 13 g, respect ively) and 12-month-old ovar iecto- mized animals (body weight 280 I 8 g; ovaries r emoved a t the age of 4 months) were in jec ted i.p. wi th 100 mg /kg OTC (Geomycin, Pl iva , Zagreb). 2 lower doses of OTC, 10 and 50 mg/kg were in jec ted in the same w a y to male and female ra ts of similar age (12-13 months old) and body weights (434 t 7, 256 ! 5 g). Blood samples were t aken 1, 4, 8, 24 and 48 h af ter OTC appl ica t ion f rom the orbi ta l venous plexus and p lasma was separa ted b y een- t r i fuga t ion a t 5000 r ev /min (3000 • for 10 min. The concent ra t ion of the an t ib io t ic was assayed on agar pla tes against Sarcina Lutes . I t can be seen on table 1 t h a t 1 h Mter admin i s t r a t ion of 100 mg/kg OTC p lasma levels of OTC were prac t ica l ly the same in all groups of animals. Af te r 4 h, the values for males and ovar iec tomized females

Table 1. OTC concentrations in plasma ([zg/ml) after a single i.p. injection of 100 mg/kg*

Time after dose (h) 1 4 8 24

Female rats A) controls 48.911.0 46.0t l .4 20.0!2.0 2.7t0.1 B) ovariectomized 49.210.6 81.1t4.7 33.5t5.0 3.7t0.3

Male rats C) controls 47.1t3.3 76.0~ 5.4 48.5t3.9 4.0t0.6

A:C p>0.1 p<0.001 p<0.001 p<0.05 A:B p>0.] p<0.001 p<0.02 p<0.001 B:C p>0.1 p>0.1 p<0.02 p>0.1

Table 2. OTC concentrations in plasma (Exg/ml) after a single i.p. injection*

Dose Sex Time after dose (h) mglkg 1 4 8

A) female 22.011.8 10.5• 0.5!0.01 50

B) male 19.0• 8.9• 3.5t0.3

C) female 4.1+0.2 1.310.1 10

D) male 3.81t-0.4 1.410.2

A:B p>O.l p>O.l C :D p>O.l p>O.l

p <0.001

* Each figure represents the mean of 8 animals ! SE. * Each figure represents the mean of 8-12 animals 1 SE.

Page 2: Sex factors and plasma levels of oxytetracycline (OTC) in rats

15.6. 1977 Specialia 739

were s ign i f i can t ly h ighe r t h a n for female controls . Af te r 8 h, the va lues were s ign i f i can t ly d i f f e ren t for all g roups of a n i m a l s ; t h e h i g h e s t were obse rved in males , lower in ova r i ec tomized females and t he lowes t in con t ro l females. Af te r 24 h t he OTC p l a s m a levels in all g roups of an ima l s decreased be low 6 txg/ml, b u t in males a n d ovar i ec to - mized females t h e y were st i l l s ign i f i can t ly h i g h e r t h a n in con t ro l females. Af t e r 48 h, OTC va lues in t h e p l a s m a were n o t measu rab le . W h e n doses of 10 a n d 50 m g / k g OTC were in jec ted , t h e a n t i b i o t i c could n o t be de t ec t ed in p l a s m a 8 a n d 24 h a f t e r t he app l i ca t i on respec t ive ly . I t is e v i d e n t f rom t ab l e 2 t h a t w i t h t h e dose of 10 m g / k g t he c o n c e n t r a t i o n s of t h e an t ib io t i c 1 a n d 4 h a f t e r the appl i - ca t ion d id n o t v a r y s ign i f i can t ly w i t h t he sex of t he an i - mal . W i t h t h e dose of 50 mg/kg , t h e p l a s m a levels in ma le a n d female r a t s d i f fered s ign i f i can t ly on ly in t h e l a t e r t i m e in te rva l , i.e. 8 h a f t e r i n j ec t i on of t h e an t ib io t i c . Discussion. S t u d y i n g t he inf luence of sex fac tors on f a t t y l iver i nduced b y t e t r acyc l ine , B r e n n e t al. ~ found no s ign i f i can t d i f ferences in t h e s e rum levels of a n t i b i o t i c b e t w e e n male a n d female r a t s 3 h a f t e r a n i.p. app l i c a t i on (50-100 mg/kg) . However , acco rd ing to our resul ts , a t t h i s ea r ly i n t e r v a l sex di f ferences are n o t l ike ly to be no t i ceab l e since t h e y seem to a p p e a r a t a l a t e r s tage. The m e c h a n i s m b y wh ich obse rved dif ferences in p l a s m a levels of OTC occur is unce r t a in . T he m e t a b o l i c t r a n s - f o r m a t i o n a n d t h e v o l u m e of d i s t r i b u t i o n seem un l ike ly to be o p e r a t i v e in th i s case, b u t t he l a t t e r possibility can- n o t be comple t e ly exc luded in ova r i ee tomized females wh ich h a v e a n increased a m o u n t of f a t t y t i s sue s. How- ever, ou r resu l t s i nd i ca t e t h a t t he increased r e t e n t i o n of

OTC in t h e bones of ma le r a t s obse rved ear l ier 4, 6 is n o t necessar i ly due to di f ferences ill t h e bone t u r n o v e r b u t could also be a r e su l t of increased OTC level in t he p lasma . Ovar i ec tomized an ima l s h a v e h i g h e r p l a s m a levels t h a n controls . T h e y nea r ly a p p r o a c h those of male r a t s in- d i ca t i ng t h a t a lack of o v a r i a n sex h o r m o n e s is p a r t l y respons ib le for the obse rved effect. However , i t shou ld be k e p t in m i n d t h a t t h e obse rved sex di f ferences in t h e p l a s m a levels of OTC m i g h t also be of cl inical impor t ance , w h e n t he an t ib io t i c is a d m i n i s t e r e d p a r e n t e r a l l y in h ighe r doses accord ing to b o d y weight . F u r t h e r s tud ies are needed to c la r i fy t he role of sex fac- to rs in OTC me tabo l i sm, especia l ly in i t s e l imina t ion , wh ich seems to be of p r i m a r y i m p o r t a n c e for e x p l a n a t i o n of p r e sen t ed da ta .

1 Acknowledgments. The authors thank Prof. K. Kostial for critical comments and suggestions !n the preparation of the manuscript. - This work was partly supported by a research grant from the US Department of Agriculture and the 'Pliva', Pharmaceutical Works, Zagreb.

2 Institute for the Control of Drugs, Moge Pijade 160, Y-41000 Zagreb, Yugoslavia.

3 Mailing address: Dr. Dinko Kello. 4 D.A. Buyske, H. IV[. Eisner and R. G. KelIy, J. Pharmac. exp.

Ther. 730, 150 (1960). 5 K.I . Hawkins, Analyt. Bioehem. 45, 128 (1972). 6 D. Dekanid, PhD Thesis, University of Zagreb, 1975. 7 K. J. Breen, S. Schenker~ M. Heimberg, Gastroenterology 69,

714 (1975}. 8 V. Korenchevsky and K. Hall, J. Endocr, 4, 103 (1945).

Uptake of noradrenaline in high altitude native's heart

J. R. Rap in , J. Couder t , L. Droue t , J . D u r a n d a n d Y. Cohen

Department o[ Pharmacology and Physiology, University Paris X I , Rue J. B. Cldment, F-92290 Chatenay Malabry (France), 22 November 7976

Summary. U p t a k e of 3 H - n o r a d r e n a l i n e b y t he h e a r t was s tud ied w i t h sect ions of i sola ted a t r i a o b t a i n e d f rom h i g h or lowlanders . I n n a t i v e h igh landers , a f f in i ty for 3 H - n o r a d r e n a l i n e b y h u m a n a t r i a is more s ign i f ican t t h a n in lowlanders . F u r t h e r m o r e , t h e Michael is M e n t e n c o n s t a n t is lower in h i g h a l t i t ude n a t i v e ' s hea r t .

People b o r n a n d res id ing p e r m a n e n t l y above 3 500 m h a v e a d i f fe ren t c i r cu l a to ry p a t t e r n f rom lowlanders . P u l m o - n a r y h y p e r t e n s i o n a n d r i g h t v e n t r i c u l a r h y p e r t r o p h y were descr ibed p rev ious ly 1. More recent ly , r educ t i on in reg iona l b lood flow a n d in ca rd iac o u t p u t were r epo r t ed ~-5. Decrease in local b lood s u p p l y was a c c o m p a n i e d b y a n increase oxygen a r t e r i o v e n o u s di f ference in such a way t h a t local oxygen c o n s u m p t i o n was m a i n t a i n e d . How- ever, t h e r e is a n excep t ion : r e d u c t i o n in c o r o n a r y b lood flow was n o t c o m p e n s a t e d b y a para l le l decrease of oxygen c o n t e n t in t h e b lood of" t he c o r o n a r y sinus, so t h a t oxygen c o n s u m p t i o n re l a t ed to h e a r t we igh t was r educed in h i g h a l t i t ude r e s iden t s 6. These resu l t s m a y be r e l a t ed to changes in t he nor- ad rene rg ie ne rvous sys tem. S tudies car r ied ou t on r a t s a r t i f i ca l ly m a i n t a i n e d in cond i t ions of h i g h a l t i t ude h a v e d e m o n s t r a t e d t h a t t h e level of ca rd iac n o r a d r e n a l i n e de- creased d u r i n g t he per iod of a c c l i m a t i z a t i o n 7-9 a n d sub- s e q u e n t l y r e t u r n e d to i t s n o r m a l ra te , p r o b a b l y fol lowing decreased use of t he t r a n s m i t t e r . This was para l le l to a s l igh t decrease of t he t u r n - o v e r found in h y p o b a r i c h y p o x i a 1~, Which m a y be due e i the r to modi f i ca t ions of b io syn thes i s or to changes in t he i n a c t i v a t i o n of nor -

adrena l ine . This p a p e r r epor t s t he di f ferences in nor - a d r e n a l i n e u p t a k e m a i n rou t e of i n a c t i v a t i o n of t h e t r a n s - mi t t e r , s tud ied on sect ions of h u m a n a t r i a col lected a t h igh a l t i t ude or low a l t i t ude in A n d e a n or E u r o p e a n popula t ions .

1 A. Rotta, A. Canepa, A. Hurtado, T. Velasquez and R. Chavez, J. appl. Physiol. 9, 328 (1956).

2 Y. Bidart, L. Drouet and J. Durand, J. Physiol. 70, 333 (1975}. 3 J. Durand and J. P. Martineaud, Ciba Found. Symposium on

High Altitude Physiology 1971, p. 159. 4 J. Durand, J. P. Marc-Vergnes, J. Coudert, M. C. Blayo and J. J.

Pocidalo. XXVI int. Congr. Physiol. Sci. Krogh Centenary Symposium, Srinagar, 12-16 October 1974.

5 M. Zelter, J. Mensch-Dechene, G. Antezana, J. Coudert and A. Loekart, IX ann. Meet Eur. Soe. clin. Invest., Rotterdam, 24-26 April 1975.

6 P .R . Motet, Ciba Found. Symposium on High Altitude Phy- siology 1971, p. 131.

7 J .N. Davis and A. Carlsson, J. Neurochem. 21, 783 (1973). 8 D.A. Hurwitz, S. M. Robinson and I. Barofsky, Psyehopharma-

eologia (Berl.) 79, 26 (1971). 9 M. Stupfel, J. Roffi, C. r. Soe. Biol. 155, 237 (1961). 10 M. Prioux-Guyonneau, J. 'Durand, J. R. Rapin and Y. Cohen,

Experientia 32, 1024 (1976).